These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23579446)

  • 21. Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development?
    Holbrook M; Malik M; Shah RR; Valentin JP
    J Pharmacol Toxicol Methods; 2009; 59(1):21-8. PubMed ID: 18834945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multi-endpoint in vivo larval zebrafish (Danio rerio) model for the assessment of integrated cardiovascular function.
    Parker T; Libourel PA; Hetheridge MJ; Cumming RI; Sutcliffe TP; Goonesinghe AC; Ball JS; Owen SF; Chomis Y; Winter MJ
    J Pharmacol Toxicol Methods; 2014; 69(1):30-8. PubMed ID: 24140389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.
    Redfern WS; Carlsson L; Davis AS; Lynch WG; MacKenzie I; Palethorpe S; Siegl PK; Strang I; Sullivan AT; Wallis R; Camm AJ; Hammond TG
    Cardiovasc Res; 2003 Apr; 58(1):32-45. PubMed ID: 12667944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of surface ECG recording in adult zebrafish reveals that the value of this model exceeds our expectation.
    Liu CC; Li L; Lam YW; Siu CW; Cheng SH
    Sci Rep; 2016 Apr; 6():25073. PubMed ID: 27125643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Thorough QT study results using action potential simulations based on ion channel screens.
    Mirams GR; Davies MR; Brough SJ; Bridgland-Taylor MH; Cui Y; Gavaghan DJ; Abi-Gerges N
    J Pharmacol Toxicol Methods; 2014; 70(3):246-54. PubMed ID: 25087753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs.
    Kågström J; Sjögren EL; Ericson AC
    J Pharmacol Toxicol Methods; 2007; 56(2):186-93. PubMed ID: 17582787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block.
    Vicente J; Johannesen L; Hosseini M; Mason JW; Sager PT; Pueyo E; Strauss DG
    PLoS One; 2016; 11(12):e0163619. PubMed ID: 28036334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Underuse of ECG monitoring in oncology patients receiving QT-interval prolonging drugs.
    Pezo RC; Yan AT; Earle C; Chan KK
    Heart; 2019 Nov; 105(21):1649-1655. PubMed ID: 31129611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of positive controls in assessing assay sensitivity in ICH S7B and ICH E14 guidance for evaluation of QT/QTc interval prolongation.
    Chiang AY; Mallinckrodt CH; Dmitrienko AA; Leishman DJ
    J Pharmacol Toxicol Methods; 2010; 62(2):143-7. PubMed ID: 20570744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micro-electrode arrays in cardiac safety pharmacology: a novel tool to study QT interval prolongation.
    Meyer T; Boven KH; Günther E; Fejtl M
    Drug Saf; 2004; 27(11):763-72. PubMed ID: 15350150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.
    De Clerck F; Van de Water A; D'Aubioul J; Lu HR; van Rossem K; Hermans A; Van Ammel K
    Fundam Clin Pharmacol; 2002 Apr; 16(2):125-40. PubMed ID: 12031065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of visualized transgenic zebrafish as a high throughput model to assay bradycardia related cardio toxicity risk candidates.
    Wen D; Liu A; Chen F; Yang J; Dai R
    J Appl Toxicol; 2012 Oct; 32(10):834-42. PubMed ID: 22744888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QT interval dynamics and triggers for QT prolongation immediately following cardiac arrest.
    Cohen RB; Dai M; Aizer A; Barbhaiya C; Peterson C; Bernstein S; Park DS; Spinelli M; Chinitz LA; Jankelson L
    Resuscitation; 2021 May; 162():171-179. PubMed ID: 33652119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database.
    Green CL; Kligfield P; George S; Gussak I; Vajdic B; Sager P; Krucoff MW
    Am Heart J; 2012 Mar; 163(3):365-71. PubMed ID: 22424006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical in vitro cardiac electrophysiology: a method of predicting arrhythmogenic potential of antihistamines in humans?
    Cavero I; Mestre M; Guillon JM; Heuillet E; Roach AG
    Drug Saf; 1999; 21 Suppl 1():19-31; discussion 81-7. PubMed ID: 10597865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation.
    Corponi F; Fabbri C; Boriani G; Diemberger I; Albani D; Forloni G; Serretti A
    Neuropsychobiology; 2019; 77(2):67-72. PubMed ID: 30544110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical strategies to assess QT liability and torsadogenic potential of new drugs: the role of experimental models.
    Joshi A; Dimino T; Vohra Y; Cui C; Yan GX
    J Electrocardiol; 2004; 37 Suppl():7-14. PubMed ID: 15534787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil.
    Vicente J; Johannesen L; Mason JW; Crumb WJ; Pueyo E; Stockbridge N; Strauss DG
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25870186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of drug-induced QT interval prolongation in telemetered common marmosets.
    Tabo M; Hara T; Sone S; Shishido N; Kuramoto S; Nakano K; Onodera H; Kimura K; Kobayashi K
    J Toxicol Sci; 2008 Aug; 33(3):315-25. PubMed ID: 18670163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.